GCGR and type 2 diabetes mellitus: reported that hepatocyte‐specific deletion of alkylation repair homologue protein 5 (Alkbh5) reduces glucose and lipid levels by inhibiting the GCGR and mTORC1 signaling pathways and that targeting Alkbh5 could reverse T2DM in diabetic mice [169].